Rheumatoid Arthritis Posts - Page 19 of 35 on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Looking for patients to test whether TNF inhibitor treatment can lower cardiovascular risk

Looking for patients to test whether TNF inhibitor treatment can lower cardiovascular risk

Posted by on Apr 25, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell The aim of this clinical trial is to determine the connection between inflammation, lipids (fats), and cardiovascular disease in rheumatoid arthritis. The main outcome to be measured is the rate of blood flow through the heart before and after treatment with certolizumab (Cimzia).  The details Cardiovascular (CV) risk is known...

Read More

Can light-intensity exercise reduce cardiovascular risk in patients with rheumatoid arthritis?

Can light-intensity exercise reduce cardiovascular risk in patients with rheumatoid arthritis?

Posted by on Apr 25, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the role of physical activity in rheumatoid arthritis (RA). The authors concluded that patients with RA are mostly active at light intensities. Light physical activity was found to reduce cardiovascular risk and also improved RA outcomes.  Some background Patients with rheumatoid arthritis (RA) can experience...

Read More

Biological drug treatments for rheumatoid arthritis – an update

Biological drug treatments for rheumatoid arthritis – an update

Posted by on Apr 16, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined data from a number of recent studies to assess biological drug treatment for rheumatoid arthritis (RA). The authors concluded that the results confirmed the effectiveness of biological drugs in treating RA. Some background Disease-modifying anti-rheumatic drugs (DMARDs) is a category of drugs defined by their use...

Read More

Being Judged: The Swinging Pendulum and Pain Management

Being Judged: The Swinging Pendulum and Pain Management

Posted by on Apr 10, 2017 in Blog, Rheumatoid Arthritis | 10 comments

Did you know that before the year 2000, poor pain management was called a major medical problem and was synonymous with poor medical care in the US?  On January 1, 2001, Congress declared 2001 to 2010 the Decade of Pain Control and Research.  Assuring that effective pain management occurred in hospitals, in 2003, the Joint Commission on Accreditation of...

Read More

Anti-TNF therapy: Predictors of success

Anti-TNF therapy: Predictors of success

Posted by on Mar 15, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell The study examined predictors of treatment success with anti-TNF drugs for rheumatoid arthritis (RA). The authors concluded that immune response and the presence of a protein in the blood can predict treatment outcomes with anti-TNF drugs. Some background In rheumatoid arthritis (RA), the immune system attacks the healthy joints the...

Read More

Examining the presence of RA in patients with and without the presence of certain antibodies in the blood

Examining the presence of RA in patients with and without the presence of certain antibodies in the blood

Posted by on Mar 14, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study compared the severity of inflammation in rheumatoid arthritis (RA) patients with (seropositive) and without (seronegative) certain antibodies in their blood. The authors concluded that seronegative patients had higher levels of inflammation than seropositive patients. Some background RA is diagnosed based on a number of...

Read More

What is next for RA patients who have not responded to conventional treatment?

What is next for RA patients who have not responded to conventional treatment?

Posted by on Feb 8, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study compared the effectiveness of two different treatments in rheumatoid arthritis (RA) patients who have not responded well to conventional treatment with disease-modifying anti-rheumatic drugs (DMARDs). The authors concluded that changing to a biological drug showed better remission rates than switching to an alternative...

Read More